The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 2,021 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 2,552 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 8,931 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 2,249 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 7,831 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 4,035 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL IN | COM | 09060J106 | 3,700 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 10,170 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 6,396 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 1,578 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 13,363 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 6,227 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| INVESCO CURNCYSHS SWISS FRAN | SWISS FRANC | 46138R108 | 5,237 | 55,200 | SH | SOLE | 55,200 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 4,105 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 2,550 | 85,000 | SH | Put | SOLE | 85,000 | 0 | 0 | |
| GENOCEA BIOSCIENCES INC | COM | 372427104 | 1,011 | 3,525,000 | SH | SOLE | 3,525,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 11,416 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 9,600 | 800,000 | SH | Put | SOLE | 800,000 | 0 | 0 | |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 8,850 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 1,588 | 79,400 | SH | Call | SOLE | 79,400 | 0 | 0 | |
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 8,394 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 4,160 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 3,588 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| MOTUS GI HLDGS INC | COM | 62014P108 | 311 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 16,968 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| OBSEVA SA | COM | H5861P103 | 6,963 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 4,719 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| PROTEOSTASIS THERAPEUTICS IN | COM | 74373B109 | 616 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 8,892 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 11,315 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 316 | 3,300 | SH | SOLE | 3,300 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 3,150 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 7,639 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| TRICIDA INC | COM | 89610F101 | 5,895 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| UROVANT SCIENCES LTD | SHS | G9381B108 | 1,977 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| VIEWRAY INC | COM | 92672L107 | 4,553 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 13,257 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 65,250 | 750,000 | SH | Call | SOLE | 750,000 | 0 | 0 | |
| ZAFGEN INC | COM | 98885E103 | 3,713 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||